AI-assisted neurosurgical planning environment with brain imaging visualization

Independent intelligence for surgical AI

Neurosurgery.ai

Tracking the research, companies, tools, and clinical adoption signals shaping AI in neurosurgery.

A concise briefing every two weeks. No hype, no spam.

Latest Brief

Research, tools, and adoption signals in one read.

Segmentation gets boring, and why that matters

Issue 1 · July 19, 2026

A launch-format issue covering segmentation maturity, regulatory tracking, adoption friction, and the first Spinal Cord Watch.

Read issue

Neurosurgery.ai Index

A curated tracker for AI-enabled neurosurgical tools.

The Index starts with a compact public table: category, use case, FDA/CE/NMPA status, evidence signal, and a clinical note. Its goal is not volume; it is a clean record that can be reviewed, cited, and improved over time.

Tool area Use case Regulatory fields Clinical note
Imaging AI Tumor segmentation, detection, triage FDA / CE / NMPA Separate validated indication from marketing claims.
Spine AI Alignment, measurement, planning Clearance pathway, region, date Workflow fit matters as much as measurement accuracy.
Spinal Cord Watch IONM, Chiari, syrinx, intramedullary tumors Mostly early evidence and research signals The neglected middle ground between brain and spine AI.

Open the Index →

Two-layer focus

Broad enough to track the field, narrow enough to be useful.

Field intelligence

AI research, companies, regulatory moves, and clinical adoption across neurosurgery.

Spinal cord depth

Intramedullary tumors, Chiari, syringomyelia, IONM, and under-covered spinal cord AI.

Professional boundary

No diagnosis, no patient advice, no image interpretation, and no clinical decision support.